Bulow HH, Linnemann M, Berg H, Lang-Jensen T, LaCour S, Jonsson T. Respiratory changes during treatment of postoperative pain with high dose transdermal fentanyl. Acta Anaesthesiol Scand1995; 39: 835–839.
2.
Gupta SK, Southam M, Gale R. System functionality and physiochemical model of fentanyl transdermal system. J Pain Symptom Manage1992; 7(suppl): S17–S26.
3.
Frolich M, Giannotti A, Modell JH. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg2001; 93: 647–648.
4.
Newshan G. Heat-related toxicity with the fentanyl transdermal patch. J Pain Symptom Manage1998; 16: 277–278.
5.
Becker LD, Paulson BA, Miller RD, Severinghaus JW, Eiger EI. Biphasic respiratory depression after fentanyl/ droperidol or fentanyl alone used to supplement nitrous oxide anesthesia. Anaesthesiology1976; 44: 291–296.
6.
Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivatives. Clin Pharmacokinet1983; 8: 422–446.
7.
Sandler AN, Baxter AD, Katz J, et al. A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects. Anaesthesiology1994; 81: 1169–1180.
8.
Grond S, Radbruch L, Lehmann KA. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl. Clin Pharmacokinet2000; 38: 59–89.
9.
McLoughlin R, McQuillan R. Transdermal fentanyl and respiratory depression. Palliat Med1997; 11: 419–419.
10.
van Bastelaere M, Rolly G, Abdullah NM. Postoperative analgesia and plasma levels after transdermal fentanyl for orthopedic surgery: double-blind comparison with placebo. J Clin Anesth1995; 7: 26–30.
11.
Latasch L, Luders S. Transdermal fentanyl against postoperative pain. Acta Anaesthesiol Belg1989; 40:113–119.
12.
Bleeker CP, Bremer RC, Dongelmans DA, van Dongen RT, Crul BJ. Inef' cacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report. Eur J Pain2001: 5: 325–329.
13.
Nugent M, Davis C, Brooks D, Ahmedzai SH. Long-term observations of patients receiving transdermal fentanyl after a randomized trial. J Pain Symptom Manage2001; 21: 385–391.
14.
Radbruch L, Sabatowski R, Petzke F, Brusch-Radbruch A, Grond S, Lehmann KA. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med2001; 15: 309–321.
